Evidence map›Paper›PMID 25221666›Full record

ArticleACS medicinal chemistry letters2014

Acyclic tethers mimicking subunits of polysaccharide ligands: selectin antagonists.

Mickael Calosso, Guillaume Tambutet, Daniel Charpentier, Gabrielle St-Pierre, Marc Vaillancourt, Mohammed Bencheqroun, Jean-Philippe Gratton, Michel Prévost, Yvan Guindon

Abstract read
In one paragraph

Article in ACS medicinal chemistry letters, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Sialyl LewisACS medicinal chemistry letters · 2025
    Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mickael CalossoBio-Organic Chemistry Laboratory, Institut de Recherches Cliniques de Montréal (IRCM) , Montréal, Québec H2W 1R7, Canada.
Guillaume TambutetBio-Organic Chemistry Laboratory, Institut de Recherches Cliniques de Montréal (IRCM) , Montréal, Québec H2W 1R7, Canada.
Daniel CharpentierBio-Organic Chemistry Laboratory, Institut de Recherches Cliniques de Montréal (IRCM) , Montréal, Québec H2W 1R7, Canada.
Gabrielle St-PierreBio-Organic Chemistry Laboratory, Institut de Recherches Cliniques de Montréal (IRCM) , Montréal, Québec H2W 1R7, Canada.
Marc VaillancourtBio-Organic Chemistry Laboratory, Institut de Recherches Cliniques de Montréal (IRCM) , Montréal, Québec H2W 1R7, Canada.
Mohammed BencheqrounBio-Organic Chemistry Laboratory, Institut de Recherches Cliniques de Montréal (IRCM) , Montréal, Québec H2W 1R7, Canada.
Jean-Philippe GrattonDépartement de Pharmacologie, Université de Montréal , Montréal, Québec H3C 3J7, Canada.
Michel PrévostBio-Organic Chemistry Laboratory, Institut de Recherches Cliniques de Montréal (IRCM) , Montréal, Québec H2W 1R7, Canada.
Yvan GuindonBio-Organic Chemistry Laboratory, Institut de Recherches Cliniques de Montréal (IRCM) , Montréal, Québec H2W 1R7, Canada ; Département de Chimie, Université de Montréal , Montréal, Québec H3C 3J7, Canada ; Department of Chemistry, McGill University , Montréal, Québec H3A 2K6, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report on the design and synthesis of molecules having E- and P-selectins blocking activity both in vitro and in vivo. The GlcNAc component of the selectin ligand sialyl Lewis(X) was replaced by an acyclic tether that links two saccharide units. The minimization of intramolecular dipole-dipole interactions and the gauche effect would be at the origin of the conformational bias imposed by this acyclic tether. The stereoselective synthesis of these molecules, their biochemical and biological evaluations using surface plasmon resonance spectroscopy (SPR), and in vivo assays are described. Because the structure of our analogues differs from the most potent E-selectin antagonists reported, our acyclic analogues offer new opportunities for chemical diversity.

Indexed as

carbohydrate recognition domainPolysaccharide-based ligandsselectin antagonistssialyl LewisXsurface plasmon resonance spectroscopy

Identifiers

PMID25221666
PMCPMC4160748

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.